Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) shares fell 2.4% during trading on Thursday . The company traded as low as $5.67 and last traded at $5.68. 13,724 shares changed hands during trading, an increase of 49% from the average session volume of 9,188 shares. The stock had previously closed at $5.81.
Elekta AB (publ) Trading Up 1.3 %
The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.74 and a current ratio of 0.99. The stock has a market cap of $2.21 billion, a price-to-earnings ratio of 23.00 and a beta of 1.23. The company’s 50 day simple moving average is $6.07 and its two-hundred day simple moving average is $6.36.
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Recommended Stories
- Five stocks we like better than Elekta AB (publ)
- The Basics of Support and Resistance
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Canada Bond Market Holiday: How to Invest and Trade
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Dividend Challengers?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.